Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information
| Autor: | Felix W. Frueh, C. Sanders, Eric J. Stanek |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
pharmacogenomics
medicine.medical_specialty Drug labeling physician business.industry drug labeling lcsh:R Alternative medicine MEDLINE Medicine (miscellaneous) Pharmacogenomic Testing lcsh:Medicine Bioinformatics Article Food and drug administration Family medicine Pharmacogenomics medicine survey business |
| Zdroj: | Journal of Personalized Medicine, Vol 3, Iss 2, Pp 111-123 (2013) Journal of Personalized Medicine Journal of Personalized Medicine; Volume 3; Issue 2; Pages: 111-123 |
| ISSN: | 2075-4426 |
| Popis: | We surveyed 10,303 United States physicians on where they obtain pharmacogenomic testing information. Thirty-nine percent indicated that they obtained this from drug labeling. Factors positively associated with this response included older age, postgraduate instruction, using other information sources, regulatory approval/ recommendation of testing, reliance on labeling for information, and perception that patients have benefited from testing. Physicians use pharmacogenomic testing information from drug labeling, highlighting the importance of labeling information that is conducive to practice application. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|